Today’s Treatment Standards and Tomorrow’s Innovations in Myasthenia Gravis
he international myasthenia gravis treatment landscape experiences continuous growth, supported by advanced diagnostic capabilities, heightened clinical recognition, and progressive therapeutic innovation